Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.32 |
| ▸ | TPSD1 | Q9BZJ3 | 2/20 | 0.32 |
| ▸ | TPSG1 | Q9NRR2 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27916807 | 0.91 | KMT2A (0.35) | KMT2AALOX15BLMPMP22MEN1 | |
| SCHEMBL11211657 | 0.89 | KMT2A (0.40) | KMT2AALOX15BLMPMP22MEN1 | |
| SCHEMBL28501210 | 0.89 | KMT2A (0.40) | KMT2AALOX15BLMPMP22MEN1 | |
| SCHEMBL3626322 | 0.87 | CYP1A2 (0.38) | KMT2AMEN1GAAHDAC6HDAC1 | |
| SCHEMBL26129393 | 0.87 | CYP1A2 (0.38) | KMT2AMEN1GAAHDAC6HDAC1 | |
| SCHEMBL26129394 | 0.87 | CYP1A2 (0.38) | KMT2AMEN1GAAHDAC6HDAC1 | |
| SCHEMBL11659278 | 0.83 | MEN1 (0.33) | KMT2AMEN1GAAHDAC6HDAC1 | |
| SCHEMBL1197166 | 0.83 | SLC1A1 (0.43) | KMT2AMEN1GAAHDAC6HDAC1 | |
| SCHEMBL1763982 | 0.82 | MEN1 (0.35) | KMT2AMEN1GAAHDAC6HDAC1 | |
| SCHEMBL28884876 | 0.81 | MEN1 (0.37) | KMT2AMEN1GAAHDAC6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12492222-B2 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | NUTRIVERT INC. (US) | 2025-12-09 | — | — | US | disclosed |
| EP-4126040-B1 | LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY | NUTRIVERT INC (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-118930602-A | Method for performing terminal allylation modification on natural amino acid or polypeptide | 南京工业大学 | 2024-11-12 | — | — | CN | disclosed |
| US-20230174577-A1 | LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY | NUTRIVERT LLC (US) | 2023-06-08 | — | — | US | disclosed |
| CN-115605226-A | Lipophilic enantiomer of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | 纽特莱特公司（US） | 2023-01-13 | — | — | CN | disclosed |
| EP-0555046-B1 | Method for determination of calcium | ORIENTAL YEAST CO LTD (JP) | 1997-07-30 | — | — | EP | disclosed |
| US-5618684-A | CALCIUM ACTIVATED TRANSGLUTAMINASE ACTS ON SUBSTRATE TO GENERATE AMMONIA; CORRELATING AMOUNT OF AMMONIA GENERATED WITH AN AMOUNT OF CALCIUM | ORIENTAL YEAST CO., LTD. (JP) | 1997-04-08 | — | — | US | disclosed |
| EP-0555046-A1 | Method for determination of calcium | ORIENTAL YEAST CO., LTD. (JP) | 1993-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174577-A1 | LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY | MIF, DNPEP, GLMN | KMT2A 3550/4885ALOX15 2264/4885BLM 3775/4885 |
| US-12492222-B2 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | MIF, DNPEP, GLMN | KMT2A 3550/4885ALOX15 2264/4885BLM 3775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.